ZWEIFACH SANFORD S has filed 5 insider transactions across 2 companies since March 2023.
Most recent transaction: a grant/award of 19350 shares of Carisma Therapeutics Inc. ($CARM) on June 26, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 26, 2024 | Carisma Therapeutics Inc. | $CARM | ZWEIFACH SANFORD S | Director | A | Stock Option (Right to Buy) | 19350 | $0.00 | 19,350.0000 | 0 | 9999.99% | 0.00% |
| March 25, 2024 | ESSA Pharma Inc. | $EPIX | ZWEIFACH SANFORD S | Not found | A | Options | 50000 | $0.00 | 50,000.0000 | 44,129,491 | 9999.99% | 0.11% |
| June 6, 2023 | Carisma Therapeutics Inc. | $CARM | ZWEIFACH SANFORD S | Director | A | Stock Option (Right to Buy) | 38700 | $0.00 | 38,700.0000 | 0 | 9999.99% | 0.00% |
| March 7, 2023 | Carisma Therapeutics Inc. | $CARM | ZWEIFACH SANFORD S | Director | A | Common stock | 413 | $0.00 | 413.0000 | 0 | 9999.99% | 0.00% |
| March 7, 2023 | Carisma Therapeutics Inc. | $CARM | ZWEIFACH SANFORD S | Director | A | Stock Option (Right to Buy) | 184621 | $0.00 | 184,621.0000 | 0 | 9999.99% | 0.00% |